Records containing: HIV Infections
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-11-27CCR5 Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
-
CLINICAL_TRIALS study record update · 2012-11-27Biobehavioral Interventions for HIV-negative Methamphetamine-using MSM
-
CLINICAL_TRIALS study record update · 2012-11-21Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)
-
CLINICAL_TRIALS study record update · 2012-11-21A Study of the Pharmacokinetic and Pharmacodynamic Interactions Between Raltegravir (Isentress) and Buprenorphine
-
CLINICAL_TRIALS study record update · 2012-11-21Pharmacokinetic Interactions Between Buprenorphine/Naloxone and Tipranavir/Ritonavir in HIV-Negative Subjects Chronically Receiving Buprenorphine/Naloxone
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-11-20Study in Healthy Volunteers to Examine the Safety, Tolerability and Plasma Pharmacokinetics of One Intramuscular (IM) Injection of a Novel TMC278 LA Formulation at 2 Different Doses (Open Label), Followed by a Placebo-controlled Part of Multiple IM Injections at a Selected Dose (Double Blind)
-
CLINICAL_TRIALS study record update · 2012-11-19A Study of the Safety, Tolerability, and Pharmacokinetics of KD-247, a Humanized Monoclonal Antibody That Recognizes the Principal Neutralizing Determinant of HIV-1, in Asymptomatic HIV-1 Seropositive Individuals Who Are Not Receiving Concurrent Antiretroviral Therapy
-
CLINICAL_TRIALS study record update · 2012-11-15Genetic Predictors of Pharmacokinetic Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin: the Role of SLCO1B1 Polymorphisms.
-
CLINICAL_TRIALS study record update · 2012-11-09A Phase I, Open Label Study to Evaluate the Safety, Tolerability and Immunogenicity of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants
-
CLINICAL_TRIALS study record update · 2012-11-07A Pilot Observational Study to Determine the Prevalence of HPV Serology in HIV Seropositive Women From Subsaharan Africa and Brasil
-
CLINICAL_TRIALS study record update · 2012-11-06Phase II Study of the Pharmacokinetics of Nevirapine and the Incidence of Nevirapine Resistance Mutations in HIV-Infected Women Receiving a Single Intrapartum Dose of Nevirapine With the Concomitant Administration of Zidovudine/Didanosine or Zidovudine/Didanosine/Lopinavir/Ritonavir
-
CLINICAL_TRIALS study record update · 2012-11-02A Randomized Controlled Study Testing the Efficacy of Immunotherapies to Control Plasma HIV RNA Concentrations Upon Interruption of Highly Active Antiretroviral Therapy
-
CLINICAL_TRIALS study record update · 2012-11-02An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) and Selected Protease Inhibitor (PI) and Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI) Therapies Among HIV-Infected Women
-
CLINICAL_TRIALS study record update · 2012-11-01A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection
-
CLINICAL_TRIALS study record update · 2012-11-01HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol
-
CLINICAL_TRIALS study record update · 2012-11-01Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma
-
CLINICAL_TRIALS study record update · 2012-10-31An HIV Vaccine Preparedness Study
-
CLINICAL_TRIALS study record update · 2012-10-31Hepatitis C Prevalence in Perinatally Infected HIV-Positive Children Enrolled in PACTG 219C
-
CLINICAL_TRIALS study record update · 2012-10-31Assessment of Cardiovascular Risk in HIV Patients
-
CLINICAL_TRIALS study record update · 2012-10-31The Effect of Therapy on the Tissue Burden of Disseminated MAC Infection as Measured by Quantitative Bone Marrow Culture and Correlation With Quantitative Blood Culture in HIV-Infected Patients
-
CLINICAL_TRIALS study record update · 2012-10-31Evaluation of the Safety, Tolerance and Pharmacokinetics of Rifabutin/Clarithromycin Combination and Rifabutin/Azithromycin Combination in HIV-Infected Patients
-
CLINICAL_TRIALS study record update · 2012-10-30A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 (CHO) BIOCINE in MF59 Emulsion Versus the Emulsion Control: Three Injections at 0, 1, and 6 Months
-
CLINICAL_TRIALS study record update · 2012-10-30A Pilot Study to Determine the Impact on Dyslipidemia of the Addition of Tenofovir to Stable Background Antiretroviral Therapy in HIV-Infected Subjects
-
CLINICAL_TRIALS study record update · 2012-10-30Mother Infant Rapid Intervention at Delivery (MIRIAD)
-
CLINICAL_TRIALS study record update · 2012-10-30A Phase I Clinical Trial to Evaluate:Part A. The Safety and Immunogenicity of Two Dose Levels of SF-2 gp120 (CHO) With or Without MTP-PE Adjuvant in the MF59 Emulsion Part B. The Safety and Immunogenicity of Five Monthly Doses of 50 mcg gp120 Protein in MF59 Emulsion (Without MTP-PE) Versus the Emulsion Control